(Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -96.68%935.69K | -81.36%6.24M | -63.56%13.65M | -48.22%21.25M | -48.22%21.25M | -36.74%28.17M | -30.18%33.5M | -32.51%37.45M | -28.33%41.04M | -28.33%41.04M |
-Cash and cash equivalents | -96.68%935.69K | -81.36%6.24M | -63.56%13.65M | -48.22%21.25M | -48.22%21.25M | -36.74%28.17M | -30.18%33.5M | -32.51%37.45M | -28.33%41.04M | -28.33%41.04M |
-Accounts receivable | 2.26%15.23K | 237.65%30.15K | -27.91%21.41K | -21.70%18.87K | -21.70%18.87K | 2.50%14.9K | -67.14%8.93K | 53.64%29.7K | 91.69%24.1K | 91.69%24.1K |
Total current assets | -81.26%5.53M | -65.40%11.74M | -51.84%18.41M | -36.36%26.95M | -36.36%26.95M | -36.18%29.5M | -29.76%33.94M | -31.64%38.22M | -26.73%42.35M | -26.73%42.35M |
Non current assets | ||||||||||
Investment properties | ---- | --281.66K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Including:Available-for-sale securities | ---- | --281.66K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Goodwill | -6.98%203.61K | -6.86%207.43K | -6.74%211.25K | -6.63%215.07K | -6.63%215.07K | -6.52%218.89K | -6.42%222.7K | -6.32%226.52K | -6.22%230.34K | -6.22%230.34K |
-Other intangible assets | --8.81M | --8.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Regulatory assets | 2.26%15.23K | 237.65%30.15K | -27.91%21.41K | -21.70%18.87K | -21.70%18.87K | 2.50%14.9K | -67.14%8.93K | 53.64%29.7K | 91.69%24.1K | 91.69%24.1K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
-accounts payable | 545.30%6.42M | 537.21%3.71M | -45.20%433.92K | 142.56%1.12M | 142.56%1.12M | --995.25K | --582.45K | --791.75K | 116.37%463.28K | 116.37%463.28K |
-Total tax payable | -83.41%5.68M | -52.19%16.62M | -44.53%15.06M | -6.92%29.14M | -6.92%29.14M | 12,195.84%34.23M | 13,893.32%34.77M | 8,046.13%27.14M | 5.00%31.31M | 5.00%31.31M |
Current accrued expenses | -13.53%335.36K | 142.00%212.87K | 236.03%612.59K | 41.84%677.72K | 41.84%677.72K | --387.84K | --87.96K | --182.3K | 82.57%477.81K | 82.57%477.81K |
Current liabilities | 388.60%6.76M | 485.36%3.92M | 7.44%1.05M | 91.42%1.8M | 91.42%1.8M | 277.59%1.38M | 10.78%670.41K | 125.81%974.05K | 69.02%941.09K | 69.02%941.09K |
Non current liabilities | ||||||||||
Derivative product liabilities | -83.41%5.68M | -52.19%16.62M | -44.53%15.06M | -6.92%29.14M | -6.92%29.14M | 12,195.84%34.23M | 13,893.32%34.77M | 8,763.43%27.14M | 5.09%31.31M | 5.09%31.31M |
Total non current liabilities | -65.08%12.44M | -42.02%20.55M | -42.73%16.1M | -4.05%30.94M | -4.05%30.94M | 5,424.26%35.61M | 4,051.87%35.44M | 3,577.44%28.12M | 6.18%32.25M | 6.18%32.25M |
Shareholders'equity | ||||||||||
Share capital | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 17.44%65.59M | 21.60%65.59M | 18.48%65.59M | 19.74%65.59M | 19.74%65.59M |
-common stock | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 17.44%65.59M | 21.60%65.59M | 18.48%65.59M | 19.74%65.59M | 19.74%65.59M |
Additional paid-in capital | ---- | ---- | 24.90%7.92M | 41.96%7.42M | 41.96%7.42M | --6.89M | --6.61M | --6.34M | 140.03%5.23M | 140.03%5.23M |
Gains losses not affecting retained earnings | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K |
Noncontrolling interests | --469.66K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total equity | -79.13%6.2M | -64.20%12.23M | -51.58%18.62M | -36.20%27.16M | -36.20%27.16M | -36.03%29.72M | -29.64%34.16M | -31.53%38.45M | -26.65%42.58M | -26.65%42.58M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data